Monday, March 1, 2021 from 3:00 to 5:00 pm at CHI’s SCOPE Summit in Orlando
The new SSS provides a forum where academics, sponsors, CROs, and other parties who share a common interest in the conduct of clinical trials can discuss the latest and most promising research that advances how we run clinical trials. We are focusing on research to improve a process that in many ways is outdated and in dire need for efficiencies. The panelists will discuss promising research and technologies that can bring data-driven, scientific practices to clinical research design and execution. These improvements should result in better decisions in new drug evaluations; providing patients with broader and more rapid access to novel medications. The panel discussion will feature the committee members below, all thought leaders, sharing ideas in a collegial atmosphere. The structure will consist of the executive panel focused on one or two big themes and will include a hackathon and group exercise focused on those themes as well. More to come…
Program Committee and Panelists
Kyle Holen, MD, Head, Development Design Center, Research & Development, AbbVie
Michelle Crouthamel, PhD, Director, Digital Health & Innovation, AbbVie
Craig Lipset, MBA, Former Head, Clinical Innovation, Pfizer; Venture Partner, Boston Millennia Partners (BMP) & FundRx; Advisor, People-Centered Research Foundation (PCRF)
Oriol Serra Ortiz, MBA, Senior Director & Head, Global Site Intelligence & Selection, Pfizer Inc
Adama Ibrahim, EMBA, Director, Digital Solutions, Novartis
Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)
Marina Filshtinsky, MD, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)